# ARCHON-1 (NCT03801902)

> Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

No report yet. It can be ordered.

- Drugs tested: monalizumab plus durvalumab; oleclumab plus durvalumab; durvalumab
- Indication: PD-L1 high locally advanced non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03801902
- Phase: PHASE1
- Status: COMPLETED
- Sponsor: National Cancer Institute (NCI)
- Conditions: Locally Advanced Lung Non-Small Cell Carcinoma; Locally Recurrent Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Unresectable Lung Non-Small Cell Carcinoma
- Interventions: Accelerated Hypofractionated Radiation Therapy; Biospecimen Collection; Computed Tomography; Durvalumab; Magnetic Resonance Imaging of the Brain with and without Contrast; Monalizumab; Oleclumab; Radiation Therapy
- Enrollment: 26
- Primary outcome: Number of Participants Experiencing a Safety Event

## Some of the questions raised in the 10 most recent indexed sources

_Automated from the 10 newest of 11 indexed sources (Feb 2019 – Dec 2025). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether durvalumab with radiotherapy alone can match concurrent chemoradiotherapy followed by consolidation durvalumab
- Whether accelerated hypofractionated radiotherapy with durvalumab performs as well as conventional fractionation
- Whether high PD-L1 expression is a sufficient basis for omitting concurrent chemotherapy

## Indexed commentary on ARCHON-1 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 11 posts on X

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=archon-1-nct03801902

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03801902", "email": "<work email>"}; the inbox owner confirms by the emailed link.
